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ABSTRACT 
 
Study Objectives: While many studies have examined the association between insomnia and depression, 
no studies have evaluated these associations 1) within a narrow time frame, 2) with specific reference to 
acute & chronic insomnia, and 3) using polysomnography. In the present study, the association between 
insomnia and first-onset depression was evaluated taking into account these considerations. 
Design: A mixed-model inception design.  
Setting: Academic research laboratory. 
Participants: Fifty-four individuals (acute insomnia (n=33), normal sleepers (n=21)) with no reported history 
of a sleep disorder, chronic medical condition, or psychiatric illness. 
Interventions: N/A 
Measurements and Results: Participants were assessed at baseline (two nights of polysomnography and 
psychometric measures of stress and mood) and insomnia and depression status were reassessed at 3 
months. Individuals with acute insomnia exhibited more stress, poorer mood, worse subjective sleep 
continuity, increased N2 sleep and decreased N3 sleep. Individuals that transitioned to chronic insomnia 
exhibited (at baseline) shorter REM Latencies and reduced N3 sleep. Individuals that exhibited this pattern, 
in the transition from acute to chronic insomnia, were also more likely to develop first-onset depression 
(9.26%) as compared to those who remitted from insomnia (1.85%) or were normal sleepers (1.85%). 
Conclusion: The transition from acute to chronic insomnia is presaged by baseline differences in sleep 
architecture that have, in the past, been ascribed to Major Depression, either as heritable traits or as 
acquired traits from prior episodes of depression. The present findings suggest that the “sleep architecture 
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stigmata” of depression may actually develop over the course transitioning from acute to chronic 
insomnia. 
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INTRODUCTION 
Despite the DSM-5 suggesting insomnia, in its acute or short-term form (i.e. meeting full criteria for 
Insomnia Disorder but with a duration less than three months), may still warrant clinical attention, little is 
actually known about the early phase of insomnia. Understanding the full course of insomnia is not only 
important to the arena of preventative sleep medicine but is underscored by accumulating evidence 
suggesting insomnia, in its chronic form, is a risk factor for a range of psychiatric and physical morbidities
1-
5
. The most compelling case for insomnia being a risk factor for future morbidity is with regard to Major 
Depression
6-10
. It has been shown that insomnia often precedes the onset of depression
11
, is present 
throughout its developmental course
12
, and treating insomnia in those with depression results in a 
reduction in depressive symptoms
13
. To that end, a recent meta-analysis suggests that chronic insomnia 
confers a two-fold risk for developing depression
14
. What is unknown, however, is where this increased risk 
for depression occurs in the natural history of insomnia as all the aforementioned studies have examined 
this link within the timeframe of chronic insomnia. 
 
While a wealth of theoretical perspectives and cross-sectional studies exist on the topic of the natural 
history of insomnia, there are only a handful of prospective longitudinal studies that provide data on this 
subject
15-21
. The primary limitations of these seminal studies pertains to 1) the clear delineation of what 
constitutes acute insomnia, 2) whether the index episode represents a first-onset or recurrence of 
insomnia, 3) the mode of assessment used (in most cases non-standard instruments and often single-item 
questions), 4) the timeframes used for assessments (in most cases either at annual or bi-annual intervals), 
and 5) the lack of objective sleep measures like polysomnography. For example, with regard to the 
timeframes between assessments, one study retrospectively assessed insomnia symptoms at six time 
points, the shortest follow-up being 2 years
15,18
, one retrospectively assessed once at five years
20
, and two 
others
17,21
, annually; one for three consecutive years the other at one time point. As such, it would be 
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difficult to reliably track the transitions between normal sleep, acute insomnia, and chronic insomnia, 
based upon the time between accounts, whilst also relying heavily on memory. Furthermore, differing 
criteria have been used in each study to define episodes of both acute (e.g. poor sleep / brief insomnia) 
and chronic insomnia (e.g. ranging between >1 month to >1 year), making definitive conclusions about the 
transition to chronic insomnia difficult. Interestingly, the only study with a follow-up period that could 
track the progression from acute insomnia to chronic insomnia as it occurred (i.e. three months) found that 
rates of chronic insomnia, in a sample of hospitalized individuals, almost doubled over the period, from 
10% to 19%
16
, suggesting a three-month incidence rate of approximately 9%. Moreover, these figures fit 
with the only epidemiological study that uses the DSM-5-defined criteria for acute insomnia (i.e. a 9.15% 
incidence over three months)
22
. 
 
From a theoretical standpoint the most well established conceptualization of the pathogenesis of insomnia 
comes from Spielman and colleagues
23--25
. Spielman’s model suggests that predispositional characteristics 
exist making some individuals more prone to insomnia than others. These characteristics, in combination 
with precipitating events, such as life stressors that may be biopsychosocial in nature, serve to initiate an 
acute episode of insomnia. An acute episode, in turn, may resolve, in tandem with the precipitating event, 
or evolve into chronic insomnia. The evolution to chronic insomnia is thought to be largely, if not wholly, 
mediated by perpetuating factors that are behavioral in nature, relating to how the individual manages 
their insomnia. As such, the initiation of insomnia and its acute phase is thought to occur in response to 
life-event stress. This viewpoint, although adopted in several subsequent models of insomnia
26-29
, and 
having received some support
30-32
, appears to be more complex than a simple stress-diathesis model. In 
essence, it may not be the life-event per se that drives the insomnia but the ability to manage the stress
33-
36
. Therefore, a potentially better indicator of the precipitating dimension of Spielman’s model may well be 
the perception of stress as opposed to the number of stressful life-events experienced. Moreover, to date 
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there has been no examination of Spielman’s model in terms of whether the circumstances surrounding 
the precipitating event (e.g. the severity of either the stressor or the initial sleep disruption) influence 
whether an individual will transit from acute or short-term insomnia to chronic insomnia. 
 
From an empirical standpoint, the most comprehensive study of the natural history of insomnia comes 
from Morin and colleagues 
21,37-38
. Here the emphasis was placed on changes over time in the number of 
reported symptoms (i.e. characterizing subjects over time as syndromal or subsyndromal for insomnia). 
Amongst the major findings from this programme of work are: 1) subsyndromal insomnia may persist for 
years and not progress to a full syndrome, 2) about 34% of subjects with subsyndromal or syndromal 
insomnia will exhibit full remission within 2 years, and 3) once syndromal, the insomnia tends to be 
persistent with 70% of subjects remaining ill within 2 years. Because this approach does not embrace the 
concepts of acute and chronic insomnia, however, it does not allow, by design, a systematic study of how 
the individual transitions between these disease stages. Finally, only one study to date has incorporated 
Polysomnography (PSG) into a natural history study
19
. A single-night of PSG, at baseline, revealed Sleep 
Latency as the only ‘biological’ marker of the transition from ‘poor sleep’ to chronic insomnia over a single 
follow-up period of, on average, seven and a half years. However, as the sample also included those with 
existing physical and psychiatric morbidities, including depression, at baseline and did not account for 
whether this was the first episode or a recurrent episode of insomnia, it would be difficult to determine 
whether this finding relates to other co-morbidities, the current episode of insomnia, or previous 
exposure(s) to insomnia. Further, as life-event stress or perceived stress were not assessed, their 
contribution to the development of insomnia in this population remains unknown. 
 
The aims of the present study were to: 1) assess whether individuals with acute insomnia exhibit more life 
events and/or greater perceived stress, anxiety, and depression than normal sleepers, 2) evaluate how 
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subjective and objective sleep continuity varies between normal sleepers and those with acute insomnia, 
3) determine if and how sleep architecture differs between normal sleepers and individuals with acute 
insomnia, 4) delineate whether subjects who exhibit a remission from insomnia differ from those that 
develop chronic insomnia on the above measures at baseline, and 5) evaluate first-onset cases of 
depression and how these occur in association with normal sleep, remitted insomnia, and chronic 
insomnia. In line with Spielman it was hypothesized that those with acute insomnia would report 
significantly more stressful life-events, score higher on perceived stress, and poorer on measures of mood 
than their normally sleeping counterparts. Further, those with acute insomnia would report subjectively 
and demonstrate objectively poorer sleep than normal sleepers. Finally, based on accumulating data that 
insomnia is a risk factor for depression, it was hypothesized that there would be significantly more ‘cases’ 
of first-onset depression in those who went on to develop chronic insomnia compared to those who either 
remitted from their insomnia, or remained normal sleepers. Due to a lack of prior evidence, there were no 
specific hypotheses in relation to which baseline characteristics (i.e. stress, mood, or sleep) would 
differentiate between those who would go on to develop chronic insomnia compared to those who would 
remit.  
 
METHODS 
Recruitment and Procedure 
Prospective subjects were recruited, as part of a larger study, from a regional media campaign, which 
included a television interview on the evening news with the study’s PI (JGE) and several local newspaper 
articles about insomnia. The television segment and newspaper articles specifically asked for volunteers to 
take part in a study on insomnia and provided contact details.  
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Potential subjects were contacted for an initial clinical interview by telephone to determine eligibility for 
the larger study. The clinical interview began with a brief description of the study including the time 
commitment required (up to 25 minutes). Interested individuals provided informed consent and began the 
interview with five questions allowing for the diagnosis of Insomnia Disorder, as defined by DSM-5 
criteria
39
. This included two questions regarding a) the individual’s principle sleep complaint of 
dissatisfaction with their sleep and b) whether this was a complaint of initial, middle and/or late insomnia, 
one question regarding sleep opportunity to establish adequate opportunity for sleep, one question 
regarding insomnia frequency (3 nights per week minimum), and one question regarding the impact of 
insomnia on daytime functioning. Additional prompts were used, where necessary, to arrive at definitive 
responses to each question (e.g. a list of markers of distress or impairment including memory impairments, 
concentration difficulties, fatigue, daytime sleepiness, distress, irritability, impaired occupational or 
psychosocial functioning, were provided if the subject was unsure whether their insomnia resulted in 
daytime dysfunction). Next, individuals were further screened for other intrinsic sleep disorders including 
Narcolepsy, Sleep-related Breathing Disorders, Parasomnias, Circadian Rhythm Disorders, and Restless 
Legs Syndrome and Periodic Limb Movement Disorder as well as medical and psychiatric histories using 
DSM-IV-TR definitions. 
 
If subjects did not meet criteria for insomnia (i.e. specifically they had to report being satisfied with their 
sleep and no current difficulty in initiating sleep, maintaining sleep, or waking too early in the morning) or 
any other sleep disorder they were classified as normal sleepers. If subjects met DSM-5 criteria for 
insomnia, a sixth question was asked ‘..for how long has this [the sleep problem] been going on?’ This was 
to differentiate acute insomnia (i.e. meeting DSM-5 criteria for Insomnia Disorder but for a duration 
between 3 days and 3 months) from chronic insomnia (i.e. meeting DSM-5 criteria for Insomnia Disorder, 
including the duration threshold of over 3 months)
39-40
. If a subject met the criteria for chronic insomnia at 
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this point they were thanked for their time and the interview was terminated. If the subject met the 
criteria for normal sleep or acute insomnia they were asked if they had a history of acute or chronic 
insomnia. Finally, all subjects with acute insomnia and normal sleepers were asked if they would like to 
take part in further follow- up surveys about their sleep. 
 
Those who completed the interview and agreed to take part in the follow-up surveys were sent login 
details for an online survey, or were mailed a paper copy of the survey the day following their telephone 
interview (baseline assessment). The survey contained a repetition of the telephone queries and additional 
Items information pertaining to sleep quality, quantity, timing and the subtype and severity of insomnia. 
Moreover, a series of standard measures were provided including instruments assessing life stress events, 
perceived stress, mood, and prospectively sampled sleep continuity using daily sleep diaries. Follow-up 
surveys, comprised of the same measures, were generated and delivered to subjects at one month, three 
months, and six months following the baseline assessment. To ensure recurrent episodes of acute 
insomnia were not mistaken for the diagnosis of chronic insomnia at follow-up points, subjects were also 
asked in each survey whether there sleep had changed since the last assessment. This was corroborated 
with the response provided to item six from the central / core questionnaire which asked ‘‘..for how long 
has this [the sleep problem] been going on?” in each survey. 
 
If at the end of the initial telephone interview a potential subject met the criteria for the main study (i.e. an 
individual with acute insomnia or a normal sleeper) and; a) lived within the Greater Glasgow and Clyde 
region of Scotland, b) reported no prior history of a sleep problem; including insomnia, psychiatric illness; 
including depression, a head injury, or a chronic medical condition, and c) they had not sought help or 
were on medication for insomnia, they were asked if they would like to take part in the in lab component 
of the present study (a PSG study of the subject’s sleep). If interested, subjects were asked to attend a 
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briefing meeting at the University of Glasgow Sleep Centre. The briefing meeting was scheduled 
approximately fifteen days prior to the first scheduled overnight (Visit 1 = Day -15) and consisted of 
completing informed consent for the overnights and to deliver their completed baseline assessment pack. 
 
As can be seen in Figure 1, 530 telephone screening interviews were conducted. 291 individuals were 
excluded based on meeting criteria for chronic insomnia. Of the remaining 239 respondents, 170 were 
designated as Normal Sleepers (NS) and 69 as individuals with Acute Insomnia (AI). Of those, 86 met the 
additional inclusion criteria for the in-lab study and were asked to participate, 68 were enrolled, and 54 
subjects completed the present study (21 normal sleepers and 33 subjects with Acute Insomnia). There 
were no differences in attrition between normal sleepers and those with acute insomnia between being 
asked to take part in the PSG assessment ??????????????????????????????2(1)=1.04, p=.31). 
 
Insert Figure 1 Here 
 
Subjects spent two consecutive nights in the sleep centre undergoing PSG study of their sleep. Subjects 
were instructed to refrain from alcohol, drugs, excessive caffeine and nicotine before arriving at the sleep 
laboratory at around 8:00 pm each night for study preparation (e.g. electrode placement, bio-calibrations, 
etc.). Bedtime was determined according to sleep diary reported bedtime. Total recording period was for 
no less than 8 hours for all subjects although time out of bed in the morning was recorded and subjects 
could leave the bedroom during the remainder of the recording period (ambulatory PSG). The PSG data 
from the screening/ adaptation first night was examined the next morning to confirm the absence of other 
co-morbid sleep disorders using the American Academy of Sleep Medicine scoring criteria
41
. All subjects 
completed a sleep diary upon awakening. After electrode removal, subjects were free to leave and 
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continue their day, as usual. For all in-lab meetings and assessments subjects were provided taxis to and 
from the laboratory. Subjects received an honorarium of £80 for their participation.  
 
The central and supplementary questions from the follow-up surveys, including the question about sleep 
changes since the last assessment, were used to determine sleep status at the three-month point. Subjects 
who met all the DSM-5 criteria at the three-month point and had not remitted between time points were 
classified as people with chronic insomnia. People who at baseline had acute insomnia but no longer met 
DSM-5 criteria at either 1 month or 3 months (i.e. they had to report being satisfied with their sleep and no 
current difficulty in initiating sleep, maintaining sleep, or waking too early in the morning) were classified 
as natural remitters. Finally, those who reported normal sleep at baseline and continued to report normal 
sleep at 1 month and 3 months (i.e. they had to report being satisfied with their sleep and no current 
difficulty in initiating sleep, maintaining sleep, or waking too early in the morning) were classified as 
normal sleepers. The protocol for both the survey and in-lab study received ethical approval from the 
University of Glasgow Ethics Committee and the National Health Service, and conformed to the Declaration 
of Helsinki’s ethical principles.  
 
Measures 
Psychological Self-report Measures  
The Social Readjustment Rating Scale: SRRS
42
 measures the number of major life events experienced over 
the previous 12-months. Each of the 42 events provided are weighted by impact (i.e. 100 points for death 
of a spouse vs. 11 for minor violation of the law) and the sum of each weighting is calculated. Scores 
between 0-149 are generally considered to confer a low susceptibility to stress-related illness, 150-299 a 
medium susceptibility, and 300 points or more a high susceptibility to stress-related illness.  
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The Perceived Stress Scale: PSS
43
 is a 14-item scale measuring individuals’ appraisal of levels of stress over 
the past month. Responses to each item are scored on a five-point Likert-type scale (0 -4) and scores range 
between 0-56 with higher scores indicating higher levels of perceived stress. 
 
The Hospital Anxiety and Depression Scale: HADS
44
 is a 14-item scale that measures symptoms of 
depression and anxiety in clinical and non-clinical populations (seven depression items and seven anxiety 
items).  Each item is rated on a four-point Likert-type scale (0-3) and scores range from 0-21 for each 
subscale. It is generally considered that scores of 11 or above are indicative of a ‘case’ of depression and/or 
anxiety in a general population sample
45
.  
 
Measures of Sleep 
Subjective Sleep. A standard sleep diary
46
 was used to derive core measures of subjective sleep continuity 
(Time in Bed [TIB], Sleep Latency [SL], Wake After Sleep Onset [WASO], Number of Awakenings [NWAK], 
Total Sleep Time [TST], and to calculate Sleep Efficiency [SE]) over a period of at least seven continuous 
days to a maximum of 14 days. Subjects were instructed to complete the diary each morning upon waking. 
Mean values were derived for each variable based upon the number of nights completed (Mean 
continuous completion 13.37 + 1.39 days). 
 
Objective Sleep. Polysomnography (PSG) was carried out over two consecutive nights and was recorded on 
a 33-channel SomnoScreen plus (S-Med, Birmingham, UK). The first night served as a screening / 
adaptation night and consisted of an extended EEG montage (including C3-A2; C4-A1), submental and 
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anterior tibialis Electromyograms (EMG), bilateral Electrooculogram (EOG), heart rate, thoracic and 
abdominal respiratory effort, air flow (by nasal-oral thermocouple and nasal thermistor), and oxygen 
saturation via finger pulse oximetry. The second night of PSG (used for the between group assessment) 
was a reduced montage and consisted of the same EEGs, EMG (submental only), EOG, and heart rate 
measurements. On both nights, percentages of and latency to each stage of sleep (Wake, N1,  N2, N3, and 
Rapid Eye Movement sleep [REM]) as well as clinical measure of sleep-onset latency (SL), wake after sleep 
onset (WASO), number of awakenings (NWAK), total sleep time (TST) and total time in bed (TIB) were 
documented. Sleep efficiency (SE) scores was derived by dividing total TST by TIB and multiplying by 100 to 
achieve a percentage. 
 
Blinding Procedures and Data Analysis 
PSG data was blind scored, using American Academy of Sleep Medicine criteria
41
, independently by a 
RPSGT qualified technician from another laboratory to ensure no experimenter bias. Identifying 
information was removed prior to electronic transfer and scorers were unaware of group assignments. A 
random sample (50%) of the PSG data was later scored by the corresponding author (JGE) to corroborate 
the scoring. Group differences were examined using Chi Square analyses for dichotomous data and 
independent t-tests (2 groups) or ANOVA’s (3 groups) with post-hoc Scheffe tests for continuous data. For 
all analyses a significance level of p<.05 was chosen. Missing data was treated by mean substitution when 
less than 5% of that scale or measure was missing. Above 5% of data missing from a measure resulted in 
casewise deletion. Percentages and percentage differences are reported for clinical caseness. For the 
present analysis, data on sleep (acute insomnia or normal sleeper) stress and mood (life events, perceived 
stress, anxiety and depression) at baseline are reported first. Then, data on sleep status (normal sleeper, 
individual with chronic insomnia, or natural remitter) and levels of depression derived from the three-
month follow-up survey are reported.  
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RESULTS 
Final Sample Composition 
The final sample consisted of 18 Males and 36 Females. As a history of a psychiatric illness or insomnia was 
exclusion criteria, neither group had a current or a past history of depression or a past history of insomnia. 
The mean age of the sample was 33.4 + 12.8. There were no significant between group differences in age 
(p=.77) or gender (p=.55) (Table 1). Additionally, none of the subjects had an Apnoea Hypopnoea Index of 
15 or above, ruling out sleep apnoea. Similarly, none of the subjects met AASM criteria for an objective 
diagnosis of Periodic Limb Movement Disorder, Bruxism, or an underlying Parasomnia.  
 
Baseline Profiles of Normal Sleepers vs. those with Acute Insomnia (Stress & Mood Measures)  
As expected, normal sleepers and those with acute insomnia differed on all the stress and mood measures; 
Social Readjustment Rating Scale Scores (p<.005), Perceived Stress Scale Scores (p<.012), and both anxiety 
(p<.001) and depression scores (p<.001). In each case those with acute insomnia reported higher stress 
and poorer mood than normal sleepers.  
 
Insert Table 1 Here 
 
Sleep Profiles in Normal Sleepers vs. those with Acute Insomnia  
The next analysis examined sleep continuity variables from the sleep diaries. As expected, normal sleepers 
and those with acute insomnia differed in terms of SL (p<.005), WASO (p<.037), TST (p<.001) and SE 
(p<.005). The groups tended to differ with respect to NWAK but this was not significant (p=.056). On each 
variable, those with acute insomnia reported sleeping worse than normal sleepers. No significant between 
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group PSG differences were observed for any of the standard five sleep continuity variables; SL, NWAK, 
WASO, TST, or SE (all at p>.05) (Table 2). Further, there were no differences in terms of latency to any 
stage of sleep; N1, N2, N3, and REM (all at p>.05) Significant differences for sleep architecture were 
observed between normal sleepers and those with acute insomnia with those with acute insomnia 
showing greater percentages of N2 (p<.03) and reduced percentages of N3 (p<.005). There were no 
differences between the groups in terms of percentages of Wake, N1, or REM (all at p>.05).  
 
Insert Table 2 Here 
 
Sub-Group Composition (Normal Sleepers vs. Natural Remitters vs. those with Chronic Insomnia)  
Of the 33 people with acute insomnia at baseline: 14 (42%) met DSM-5 criteria for insomnia at 3 months 
and reported no changes in sleep status over the previous 3 months were classified as subjects with 
Chronic Insomnia; and 19 (58%) no longer met the criteria for insomnia, either reporting remission by 1 
month (n = 15) with no new onset by 3 months or remission by 3 months (n = 4), and were classified at 
Natural Remitters. None of the original 21 normal sleepers reported the onset of a sleep problem at 1 or 3 
months and were still classified as Normal Sleepers.  
 
Differences between Groups (Normal Sleepers vs. Natural Remitters vs. those with Chronic Insomnia) on 
Baseline Measures of Stress, Mood, and Sleep 
The three groups (Normal Sleeper, Natural Remitter, and those with Chronic Insomnia), while continuing 
not to differ with respect to Age and Sex (all at p>.05), differed on four of the five baseline self-report sleep 
continuity measures; SL (p<.003), WASO (p<.017), TST (p<.001), and SE (p<.005), but not NWAK(p=.16) 
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where the natural remitters and chronic insomnia groups exhibited greater morbidity than normal sleepers 
but did not differ from each other (i.e. no differences between those with chronic insomnia and natural 
remitters). Similarly, the three groups differed on all the baseline measures of stress and mood, but again 
the natural remitter and chronic insomnia groups did not differ on these measures (see Table 3). The three 
groups did not differ with respect to PSG assessed sleep continuity (all at p>.05). In terms of comparisons 
on sleep architecture, differences were evident within REM Latency (p<.01) and percentage of N3 (p<.006): 
The chronic insomnia group exhibited a reduced REM latency as compared to normal sleepers (p<.05) and 
natural remitters (p<.05) and those with chronic insomnia exhibited reduced N3 compared to normal 
sleepers (p<.05).  
 
Insert Table 3 Here 
 
Assessment of First-onset Depression (Normal Sleeper vs. Natural Remitter vs. those with Chronic Insomnia 
at Follow Up)   
At the three-month follow-up there was a significant difference between the three groups in terms of 
depression scores from the HADS (F(2,51)=8.61, p<.001). Post-hoc tests revealed no significant differences 
between those who had remitted (6.16 + 3.34) and those who remained normal sleepers (3.14 + 2.92) or 
those who became chronic (7.79 + 4.06) but a significant difference between the normal sleepers and 
those who had developed chronic insomnia (p<.05). Using the cut-off scores for a ‘clinical’ case of 
depression (i.e. HADS scores <11), 0 of the normal sleepers had a case of depression at baseline, 0 at 1-
month, and 1 at the 3-month follow-up. As such there was an overall increase of 1 case of depression 
between baseline and three months in the normal sleeping group. For the natural remitters, at baseline 
there were 0 cases, 1 case at one-month and still one case at the 3-month follow-up, thus there was an 
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overall increase of 1 case over the three-month period. For the subjects with chronic insomnia, there were 
0 cases at baseline, 2 cases at one-month, and 5 cases at follow-up, suggesting an increase of 5 cases 
between baseline and the three-month follow-up.  
 
DISCUSSION 
The primary aims of this study were to determine whether differences existed in terms of life events, 
perceived stress, mood, and sleep, both subjectively and objectively, between those with acute insomnia 
and normal sleepers. Additionally, to determine whether any baseline characteristics differentiated those 
who would remit from insomnia from those who would transition to chronic insomnia. The final aim of the 
study was to examine whether those who developed chronic insomnia would report more cases of first-
onset depression compared to those who were normal sleepers or remitted before the insomnia became 
chronic. 
 
The first findings, that individuals with acute insomnia exhibited more life events, greater perceived stress, 
anxiety, and depression than normal sleepers, supports Spielman’s model in that insomnia appears to be 
precipitated by stress. Importantly, where previous research has shown experimentally induced stress, 
prior to sleep onset, to demonstrate this relationship
36,47-50
, the present study now documents this 
association in a naturalistic way during the acute phase of insomnia. Interestingly it also appears that the 
number of life events experienced, levels of perceived stress, and levels of negative mood had no bearing 
on whether an individual would go on to develop chronic insomnia or not. As such it appears that the 
severity and impact of the initial stressor are unlikely to be the main drivers in the progression from acute 
to chronic insomnia.  
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The finding that there were reliable subjective differences in most sleep continuity dimensions (SE, SL, 
WASO, and TST) is unsurprising as subjective reports of difficulties in initiating or maintaining sleep are 
central criteria for a diagnosis of both acute and chronic insomnia. Although, an, examination of the means 
and standard deviations of these variables, particularly SL and WASO, shows that, like chronic insomnia, 
acute insomnia is not a homogeneous phenomenon and is characterised by extreme between-subject 
variability in terms of overall severity and presenting subtype. Normal sleepers and individuals with acute 
insomnia did not exhibit objective sleep continuity differences but did exhibit sleep architecture 
differences. The lack of PSG sleep continuity findings is, to some extent, surprising. Given an adaptation 
night, at least small observable differences would be expected between the normal sleeper and acute 
insomnia groups. The absence of such findings may be a reflection of within-subject night-to-night 
variability in insomnia severity
51- 53
 and further evidence that multiple days or weeks of data are required 
for stable and reliable sleep continuity estimates. Alternatively, it may be that the perceptual aspect of 
insomnia (the inability to perceive sleep as sleep) develops in advance of frank sleep initiation and 
maintenance problems or there is a sequence of effects that cannot be resolved with the present 
“sampling rate”. Whatever the case the lack of sleep continuity findings further underscores the wisdom of 
the Academy of Sleep Medicine’s recommendation that PSG is not required for a diagnosis of insomnia and 
allows for the prospect of early intervention. That is, one is not required to wait until objective findings are 
present to initiate treatment.  
 
The PSG data revealed two differences between normal sleepers and subjects with acute insomnia with 
respect to sleep architecture. Acute insomnia was characterised by ‘lighter’ sleep (lower percentages of N3 
and higher percentages of N2 sleep). These findings are consistent with the perspective that the sleep of 
acute insomnia may be less perceptible as sleep, or at least perceived as less restorative
27
. Specifically, 
previous studies have shown that individuals with chronic insomnia, woken successively during N2 sleep, 
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are more likely to perceive the period before awakening as wakefulness as opposed to sleep
54-55
. 
Moreover, one study demonstrated ‘abnormal’ ERP responses during N2 sleep in individuals with chronic 
insomnia, compared to controls, suggesting that cortical-arousal protective processes are impaired in this 
population
56
. Whether the current findings simply reflect two biological markers specific to this population 
or an increased opportunity for enhanced information processing during sleep (i.e. a vulnerability inherent 
in acute insomnia as well as chronic insomnia) remains to be seen, but is worthy of future enquiry. 
Certainly, the fact that those with acute insomnia reported poorer sleep on almost all sleep continuity 
dimensions compared to normal sleepers but did not demonstrate any objective differences hints towards 
the latter hypothesis. 
 
Despite the findings regarding stress as a precipitating factor for acute but not chronic insomnia is 
valuable, it may well be that the PSG data and follow-up depression data are the most suggestive. The two 
sleep architecture differences (i.e. reduced N3 and decreased REM latency in those who become chronic) 
have the potential to provide an insight into the natural history of insomnia and its association with 
depression. Traditionally in pure cross sectional designs decreased REM latency and decreased N3 are not 
seen in chronic insomnia
57
. However, this pattern is commonly observed in other psychiatric disorders, 
most notably preceding and during an episode of depression
58-62
. This would suggest, as is commonly held, 
that reduced N3 and decreased REM latency are features of depression (expressed or unexpressed). In the 
present study, it seems unlikely that these differences relate to the number of life events experienced, 
levels of perceived stress, mood, or severity of sleep complaint as these factors did not differ between 
those who remitted and those who transited to chronic insomnia. Further, given our observation that it 
was the subjects with chronic insomnia that disproportionately exhibited first-onset depression (i.e. a 
9.26% increase compared to 1.85% in normal sleepers and 1.85% in those who naturally remitted), this 
suggests, as one possibility of many, that acute insomnia may represent the ‘initial wound’ to future 
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depression and this, in combination with an unknown factor, results in reduced REM latency and 
decreased N3 in subjects that develop chronic insomnia. Once chronic, both the insomnia and the reduced 
REM latency and N3 represent risk factors for first-onset depression. These speculations should however 
be treated with a certain degree of caution as the mean REM Latency, at baseline, in those who went on to 
develop chronic insomnia (i.e. a mean of 66 minutes) was higher than what is generally considered in the 
region for primary depression (i.e. 50-65 minutes)
63-64
. However, a REM Latency of 70 minutes has been 
shown to confer a sensitivity of 82% and specificity of 69% to detect ‘all cause’ depression
65 
and several 
studies have demonstrated a mean REM Latency, similar to the data presented here (i.e. mean REM 
Latencies of 65,68 and 69 minutes)
66-68
, in patients with primary depression. Finally, to our knowledge REM 
Latency has never been examined in first-onset depression and so it is unknown whether the observed 
REM Latencies in this population are outside the norm. As such, of the many questions that remain here 
are 1) do the two phenomenon (reduced N3 and shorter REM Latencies) represent the same risk or 
different risks that may interact, 2) whether the reduced REM latency and N3 observations represent a 
trait or state vulnerability, and 3) does reduced REM latency and N3 continue to be present as a “scar” and 
a risk factor for depression if the chronic insomnia remits or is treated. Certainly, in terms of the first 
question, qEEG would be a useful addition and would also help determine whether this reduced REM 
Latency signifies increased REM pressure and/or a weakening of the non-REM system
69-71
. Moreover, in 
terms of the second question, the assessment of a gene / REM Latency interaction would add to the 
existing literature which currently leans towards a trait vulnerability for depression, at least in terms of 
reduced REM Latency
72-74
. Clearly these issues await natural history studies that adopt some of the 
strategies deployed here but in substantially larger samples. 
 
Limitations. 
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The findings should be with interpreted with caution. This is the first study of its kind in terms of examining 
objective and subjective sleep in naturally occurring acute insomnia and examining baseline characteristics 
with a short temporal resolution. Moreover, psychiatric illnesses, current status and history, were only 
assessed by self-report, which may have been subject to a self-presentation bias. As such, replication and 
extension (e.g. having access to medical and psychiatric records) are vital to confirm the validity of the 
present findings. The results are also limited in terms of the nature or type of the insomnia. As with most 
insomnia studies, the sample was not classified in terms of presenting type of insomnia (e.g. Idiopathic, 
Paradoxical, etc). Similarly, there were no individuals recruited who objectively demonstrated a co-
occurring sleep disorder. Whilst these findings do strengthen our understanding of ‘pure’ acute insomnia 
and fit with what has been observed in the prevalence and incidence of acute insomnia (i.e. a higher 
prevalence and incidence of ‘pure’ cases compared to complex cases)
22
 the extent to which these findings 
are replicable to those with complex acute insomnia in unknown. 
 
Conclusion 
The present study sought, for the first time, to characterize stress, sleep, and mood during acute insomnia 
and to determine whether any of the factors present at the onset of insomnia differentiated those who 
would transit to chronic insomnia from those who would remit. Further, whether those who developed 
chronic insomnia were also more likely to develop first-onset depression, compared to those who remitted 
or remained normal sleepers. The findings suggest acute insomnia is characterized by stress (the number 
of life events experienced and the perception of stress), poorer mood, and poorer subjective sleep. 
Moreover, acute insomnia appears to be characterized by longer periods of lighter sleep.  Finally, there is a 
substantial literature suggesting insomnia is a risk factor for depression
6-11
. The present data tentatively 
suggests that it is acute insomnia that is associated with the vulnerability for first-onset depression. 
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Interestingly, the figures of those who developed first-onset depression over the acute period were over 
twice the estimated annual incidence
75
, reflecting the findings from a recent meta-analysis
15
. 
 
Acknowledgements: 
This study was funded by the Economic and Social Research Council (RES-061-25-0120-A). The funders had 
no role in any aspect of the study or production of the manuscript. The PI (JGE) had full access to all of the 
data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
25 
REFERENCES 
 
1. Vahtera, J., Pentti, J., Helenius, H., Kivimaki, M. Sleep disturbances as a predictor of long-term 
increase in sickness absence among employees after family death or illness. Sleep 2006; 29(5), 673. 
 
2. Vgontzas, A.N., Liao, D., Bixler, E. O., Chrousos, G. P., Vela-Bueno, A. Insomnia with objective short 
sleep duration is associated with a high risk for hypertension. Sleep 2009; 32:491-97. 
 
3. Taylor, D. J., Lichstein, K. L., Durrence, H. H. Insomnia as a health risk factor. Behavioral Sleep 
Medicine 2003; 1(4), 227-247. 
 
4. Schwartz, S. W., Cornoni-Huntley, J., Cole, S. R., Hays, J. C., Blazer, D. G., Schocken, D. D. Are sleep 
complaints an independent risk factor for myocardial infarction?. Annals of epidemiology 
1998; 8(6), 384-392. 
 
5. Chien, K. L., Chen, P. C., Hsu, H. C., Su, T. C., Sung, F. C., Chen, M. F., Lee, Y. T. Habitual sleep 
duration and insomnia and the risk of cardiovascular events and all-cause death: report from a 
community-based cohort. Sleep 2010; 33(2), 177. 
 
6. Ford D, Kamerow D. Epidemiologic study of sleep disturbance and psychiatric disorders: an 
opportunity for prevention? JAMA 1989;262:1479-84. 
 
7. Perlis ML, Smith LJ, Lyness JM, Matteson SR, Pigeon WR, Jungquist CR, Tu X. Insomnia as a risk 
factor for the onset of depression in the elderly. Behavioral Sleep Medicine. 2006;4(2): 104-113. 
  
 
26 
 
8. Pigeon WR, Hegel M, Unutzer J, Fan MY, Sateia MJ, Lyness JM, Phillips C, Perlis, ML. Is insomnia a 
perpetuating factor for late-life depression in the IMPACT cohort? Sleep 2008;31:481-8. 
 
9. Riemann D, Voderholzer U. Primary Insomnia: A risk factor to develop depression. Journal of 
Affective Disorders.2003; 76: 255-259. 
 
10. Riemann D, Berger M, Voderholzer U. Sleep and depression- results from psychobiological studies: 
an overview. Biological Psychology. 2001; 57: 67-103. 
 
11. Perlis, M. L., Giles, D. E., Buysse, D. J., Tu, X., Kupfer, D. J. Self-reported sleep disturbance as a 
prodromal symptom in recurrent depression. Journal of Affective Disorders, 1997; 42(2-3), 209-212. 
 
12. Taylor, D. J., Lichstein, K. L., Durrence, H. H., Reidel, B. W., Bush, A. J. Epidemiology of insomnia, 
depression, and anxiety. Sleep 2005; 28(11), 1457. 
 
13. Manber, R., Edinger, J. D., Gress, J. L., San Pedro-Salcedo, M. G., Kuo, T. F., Kalista, T. Cognitive 
behavioral therapy for insomnia enhances depression outcome in patients with comorbid major 
depressive disorder and insomnia. Sleep 2008; 31(4), 489. 
 
  
 
27 
14. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann 
D. Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological 
studies. Journal of Affective Disorders. 2011; 135: 10-19. 
 
15. Vollrath M, Wicki W, Angst J. The Zurich Study VIII. Insomnia: association with depression, anxiety, 
somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989;239:113-24. 
 
16. Griffiths MF, Peerson A. Risk factors for chronic insomnia following hospitalization. Journal of 
Advanced Nursing 2005; 49: 245-253. 
 
17. Jansson-Frojmark M, Linton S. The course of insomnia over one-year: A longitudinal study in the 
general population of Sweden. Sleep 2008; 31: 881-886. 
 
18. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rossler W. Prevalence, course, and comorbidity of 
insomnia and depression in young adults. Sleep 2008;31:473-80. 
 
19. Fernandez-Mendoza, J., Vgontzas, A. N., Bixler, E. O., Singareddy, R., Shaffer, M. L., Calhoun, S. L., 
Liao, D. Clinical and polysomnographic predictors of the natural history of poor sleep in the general 
population. Sleep 2012; 35(5), 689. 
 
  
 
28 
20. Vahtera, J., Kivimäki, M., Hublin, C., Korkeila, K., Suominen, S., Paunio, T., Koskenvuo, M. Liability to 
anxiety and severe life events as predictors of new-onset sleep disturbances. Sleep 2007; 30(11), 
1537. 
 
21. Morin CM, Belanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Merette C, Baillargeon L, Gregoire JP. 
The natural history of insomnia: a population-based 3 year longitudinal study. Archives Internal 
Medicine. 2009;169(5): 447-453. 
 
22. Ellis JG, Perlis ML, Neale LF, Espie CA, Bastien CH. The Natural History of Insomnia: Focus on 
Prevalence and Incidence of Acute Insomnia. Journal of Psychiatric Research, 2012; 10: 1278-1285. 
 
 
23. Spielman AJ. Assessment of insomnia.Clinical Psychology Review 1986; 6: 11-25. 
 
24. Spielman AJ, Caruso L, Glovinsky PB. A Behavioural Perspective on Insomnia Treatment. Psychiatric 
Clinics of North America. 1987; 10: 541-553. 
 
25. Spielman AJ, Nunes J, Glovinsky PB. Insomnia. Neurol. Clin. 1996; 14: 513-543. 
 
26. Espie CM. Insomnia: conceptual issues in the development, persistence, and treatment of sleep 
disorder in adults. Annu Rev Psychol 2002; 53:215-43. 
 
  
 
29 
27. Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK. Psychophysiological insomnia: the 
behavioural model and a neurocognitive perspective. J Sleep Res 1997;6:179-88. 
 
28. Cano G, Mochizuki T, Saper CB. Neural circuitry of stress-induced insomnia in rats. J Neurosci 2008; 
28:10167-87. 
 
29. Harvey AG. A cognitive model of insomnia. Behav Res Ther 2002; 40:869-93. 
 
30. Bastien, C. H., Vallieres, A., & Morin, C. M. Precipitating factors of insomnia. Behavioral Sleep 
Medicine 2004; 2(1), 50-62. 
 
31. Healey, E. S., Kales, A., Monroe, L. J., Bixler, E. O., Chamberlin, K., Soldatos, C. R. Onset of insomnia: 
role of life-stress events. Psychosomatic Medicine 1981; 43(5), 439-451. 
 
32. Geng, F. U. L. E. I., Fan, F., Mo, L., Simandl, I., Liu, X. Sleep problems among adolescent survivors 
following the 2008 Wenchuan earthquake in China: a cohort study. The Journal of clinical 
psychiatry 2013; 74(1), 67-74. 
 
33. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. 
Psychosom Med 2003; 65:259-67. 
 
34. Ellis J, Cropley M. An examination of thought control strategies employed by acute and chronic 
  
 
30 
insomniacs. Sleep Med 2002; 3:393-400. 
 
35. Sadeh, A., Keinan, G., Daon, K. Effects of stress on sleep: the moderating role of coping style. Health 
Psychology 2004; 23(5), 542. 
 
36. Germain A, Buysse DJ, Omao H, Kupfer DJ, Hall M. Psychophysiological recativity and coping styles 
influence the effects of acute stress exposure on rapid eye movement sleep. Psychosom Med 2003; 
65:857-64. 
 
37. LeBlanc M, Beaulieu-Bonneau S, Merette C, Savard J, Morin CM. Psychological and health-related 
quality of life factors associated with insomnia in a population-based sample. Journal of 
Psychosomatic Research. 2007; 63(2): 157- 166. 
 
38. LeBlanc M, Merette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors for 
insomnia in a population-based sample.Sleep. 2009; 32(8): 1027-1037. 
 
39. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Proposed 
5th Edition. (www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=65).Retrieved 
10/08/2012. 
 
40. Ellis, J. G., Gehrman, P., Espie, C. A., Riemann, D., Perlis, M. L. Acute insomnia: Current 
conceptualizations and future directions. Sleep medicine reviews, 2012; 16(1), 5-14. 
  
 
31 
 
41. Iber, C. The AASM manual for the scoring of sleep and associated events: rules, terminology and 
technical specifications. American Academy of Sleep Medicine, 2007. 
 
42. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res. 1967 11 (2): 213–8. 
 
43. Cohen S, Kamarck T, Mermelstein R. (1983). A global measure of perceived stress. Journal of Health 
and Social Behavior, 24, 385-396. 
 
44. Zigmond AS, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 
1983, 67, 361–370. 
 
45. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical 
sample. 2001 British Journal of Clinical Psychology, 4, 429-434. 
 
46. Morin CM. Insomnia: Psychological assessment and management. New York: Guilford Press 1993. 
 
47. Hall M, Vasko R, Buysse D, Ombao H, Chen Q, Cashmere JD, Kupfer D, Thayer JF. Acute stress affects 
heart rate variability during sleep. Psychosomatic Medicine 2004; 66: 56-62.18. 
 
  
 
32 
48. Haynes SN, Fitzgerald SG, Shute G, O’Meary M. Responses of psychophysiologic and subjective 
insomniacs to auditory stimuli during sleep: a replication and extension. Journal of Abnormal 
Psychology 1985; 94: 338-345. 
 
49. Haynes SN, Adams A, Franzen M. The effects of pre-sleep stress on sleep-onset insomnia. Journal of 
Abnormal Psychology 1981; 90: 601-606. 
 
50. Gross RT, Borkovec TD. Effects of cognitive intrusion manipulation on the sleep-onset latency of 
good sleepers. Behavior Therapy 1982; 13: 112-116. 
 
51. Vallieres A, Ivers H, Bastien CH, Beaulieu-Bonneau S, Morin CM. Variability and predictability in 
sleep patterns of chronic insomniacs. J Sleep Res. 2005, 14(4):447–53. 
 
52. Perlis ML, Swinkels CM, Gehrman PR, Pigeon WR, Matteson-Rusby SE, Jungquist CR. The incidence 
and temporal patterning of insomnia: A pilot study. Journal of Sleep Research, 2010; 19: 31-35. 
 
53. Buysse DJ, Cheng Y, Germain A, Moul DE, Franzen P, Fletcher M, Monk TH. Night-to-Night Sleep 
Variability in Older Adults with and Without Chronic Insomnia. Sleep Medicine, 2010, 11: 56-71. 
 
  
 
33 
54. Borkovec, T. D., Lane, T. W., VanOot, P. H. Phenomenology of sleep among insomniacs and good 
sleepers: Wakefulness experience when cortically asleep. Journal of Abnormal Psychology 1981: 
90(6), 607. 
 
55. Mercer, J. D., Bootzin, R. R., Lack, L. C.. Insomniacs' perception of wake instead of sleep. Sleep 
2002, 25(5), 564-572. 
 
56. Yang, C., Lo, H. ERP evidence of enhanced excitatory and reduced inhibitory processes of auditory 
stimuli during sleep in patients with primary insomnia. Sleep 2007,30(5), 585. 
 
57. Feige B, Al-Shajlawi A, Nissen C, Voderholzer U, Hornyak M, Spiegelhalder K, Kloepfer C, Perlis M, 
Riemann D. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison 
of polysomnographic and subjective sleep in 100 patients. Journal of Sleep Research 2008, 17: 180–
190. 
 
58. Perlis ML , Giles DE, Buysse DJ, Thase ME, Tu X, Kupfer D. Which depressive symptoms are related 
to which sleep electroencephalographic variables? Biological Psychiatry, 1997; 42: 904-913. 
 
59. Giles DE, Kupfer DJ, Roffwarg HP. EEG sleep before and after the first episode of depression. Sleep 
Res 1990; 19: 161. 
 
  
 
34 
60. Benca RM, Okawa M, Uchiyama M, Ozaki S, NakajimaT, Shibui K, Obermeyer WH. Sleep and mood 
disorders. Sleep Medicine Reviews 1997; 1: 45-56. 
 
61. Giles DE, Roffwarg HP, Schlesser MA, Rush AJ. Which endogenous depressive symptoms relate to 
REM latency reduction? Biol Psychiatry 1986; 21: 473– 482. 
 
62. Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ. Delta Sleep Ratio: A Biological Correlate of Early 
Recurrence in Unipolar Affective Disorder. Archives of General Psychiatry 1990; 47: 1100-1105. 
 
63. Rush, A. J., Erman, M. K., Giles, D. E., Schlesser, M. A., Carpenter, G., Vasavada, N., Roffwarg, H. P. 
Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Archives 
of General Psychiatry 1986; 43(9), 878. 
 
64. Riemann, D., Hohagen, F., Bahro, M., Berger, M. Sleep in depression: the influence of age, gender 
and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 
86. European Archives of Psychiatry and Clinical Neuroscience 1994; 243(5), 279-290. 
 
65. Akiskal, H. S., Lemmi, H., Yerevanian, B., King, D., Belluomini, J. The utility of the REM latency test in 
psychiatric diagnosis: a study of 81 depressed outpatients. Psychiatry Research 1982; 7(1), 101-110. 
 
  
 
35 
66. Rush, A. J., Giles, D. E., Jarrett, R. B., Feldman-Koffler, F., Debus, J. R., Weissenburger, J., Roffwarg, 
H. P. Reduced REM latency predicts response to tricyclic medication in depressed 
outpatients. Biological psychiatry 1989; 26(1), 61-72. 
 
67. Giles, D. E., Schlesser, M. A., Rush, A. J., Orsulak, P. J., Fulton, C. L., & Roffwarg, H. P. 
Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: A 
replication and extension. Biological psychiatry 1987; 22(7), 872-882. 
 
68. Rush, A. J., Giles, D. E., Roffwarg, H. P., & Parker, C. R. Sleep EEG and dexamethasone suppression 
test findings in outpatients with unipolar major depressive disorders. Biological Psychiatry 1982; 
17(3), 327-341. 
 
69. Kupfer, D. J., & Ehlers, C. L. Two roads to rapid eye movement latency. Archives of General 
Psychiatry 1989; 46(10), 945. 
 
70. Buysse, D. J., & Kupfer, D. J. Diagnostic and Research Applications of Electroencephalographic Sleep 
Studies in Depression Conceptual and Methodological Issues. Journal of Nervous and Mental 
Disease 1990; 178(7), 405-414. 
 
71. Berger, M., & Riemann, D. REM sleep in depression—an overview. Journal of Sleep Research 1993; 
2(4), 211-223. 
 
  
 
36 
72. Giles, D. E., Roffwarg, H. P., & Rush, A. J. REM latency concordance in depressed family members. 
Biological Psychiatry 1987; 22(7), 910-914. 
 
73. Giles, D. E., Biggs, M. M., Rush, A. J., & Roffwarg, H. P. Risk factors in families of unipolar 
depression. I. Psychiatric illness and reduced REM latency. Journal of Affective Disorders 1988; 
14(1), 51-59. 
 
74. Giles, D. E., Kupfer, D. J., Rush, A. J., & Roffwarg, H. P. Controlled comparison of electrophysiological 
sleep in families of probands with unipolar depression. American Journal of Psychiatry 1998; 155(2), 
192-199. 
 
75. Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Brooks, P. Years lived with 
disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for 
the Global Burden of Disease Study 2010. The Lancet 2013; 380(9859), 2163-2196. 
 
 
Screening Interviews (N = 530)  
People with Chronic 
Insomnia N = 291 
(excluded) 
Normal Sleepers 
(NS)  
N = 170 
People with Acute  
Insomnia (AI) 
N = 69 
AI Agreed to Take 
Part 
N = 39 
NS Agreed to Take 
Part 
N = 29 
AI Completed PSG  
N = 33 
NS Completed 
PSG  
N = 21 
Exclusion Criteria: 
 
Geographically out of area  
(NS = 74 / AI = 9)  
Taking sleep meds or getting 
help  for sleep (NS = 6 / AI = 3) 
Previous history of sleep 
problem (N = 34 / AI = 6) 
History of psychiatric or 
chronic medical illness 
 (NS = 15 / AI = 6) 
Loss of Data: 
 
Less than 7 days diary or 
actigraphy (NS = 3 / AI = 1) 
Loss of PSG signal  
(NS = 3 / AI = 4) 
Did not complete 3 month 
follow up (NS = 0 / AI = 1) 
Did not complete two nights 
PSG (NS = 2 / AI = 0) 
NS asked to take 
part  
N = 41 
AI asked to take part 
N = 45 
Developed Chronic 
Insomnia at 3 
Months  
N = 14 
Remained Normal 
Sleepers at 3 Months 
N = 21 
Remitted from 
Insomnia by 3 
Months 
N = 19 
Inclusion Criteria  
 
DSM-5 Criteria (Insomnia Disorder) 
? A principle dissatisfaction with sleep (principle 
complaint) 
? Reported difficulty in initiating sleep / 
maintaining sleep, or early morning awakening 
despite adequate opportunity 
? Problem 3 or more nights per week 
? Reports of at least one daytime dysfunction 
? Length of insomnia (under three months for 
acute insomnia over three months for chronic 
insomnia) 
 
Normal Sleeper 
? Does not meet DSM-5 Criteria for Insomnia 
? Satisfied with sleep 
? No reports of difficulty in initiating sleep / 
maintaining sleep, or early morning awakening  
Table 1: Baseline Group Differences in Demographics and Self-report Measures
Baseline Variable Cluster
Normal Sleepers
(n = 21)
People with Acute
Insomnia (n = 33)
t
Demographics
Age 34.14 (13.78) 33.06 (12.39) -.3
Sex 13 Female (61.91%) 23 Female (69.7%) X
2
= .35
Sleep Continuity (Diary)
Sleep Latency (minutes) 14.53 (9.73) 27.43 (15.83) 3.35**
Number of Awakenings .89 (.78) 1.42 (1.05) 1.96
Wake After Sleep Onset (minutes) 11.12 (14.96) 27.62 (33.16) 2.14*
Total Sleep Time (minutes) 433.35 (38.82) 377.21 (56.97) -3.79***
% Sleep Efficiency 83.18 (8.42) 74.55 (10.59) -3.15**
Measures of Stress and Mood
Life Event Scale Scores 106.63 (61.57) 174.62 (93.1) 2.96**
Perceived Stress Scores 26.1 (4.25) 29.36 (4.64) 2.61*
HADS: Anxiety 4.62 (3.06) 9.73 (4.3) 4.73***
HADS: Depression 1.38 (2.04) 5.42 (2.93) 4.53***
* Indicates a significant difference between the three groups at p<.05
** Indicates a significant difference between the three groups at p<.01
*** Indicates a significant difference between the three groups at p<.001
Table 2: Baseline Group Differences in Objective Sleep Parameters
Baseline Variable Cluster
Normal Sleepers
(n = 21)
People with Acute
Insomnia (n = 33)
t
PSG Sleep Continuity
Parameters
Sleep Latency (minutes) 8.31 (8.32) 11.61 (14.54) .94
Number of Awakennings 4.448 (2.14) 4.3 (2.8) -.24
Wake After Sleep Onset (minutes) 30.45 (18.69) 33.09 (28.18) .38
Total Sleep Time (minutes) 402.02 (62.47) 389.49 (50.17) -.81
% Sleep Efficiency 90.83 (5.09) 88.94 (7.22) -1.05
PSG Sleep Architerture
Parameters
Latency to Stage 1 9.64 (11.6) 8.89 (8.12) -.28
Latency to Stage 2 13.81 (10.21) 13.80 (9.16) -.01
Latency to Slow Wave Sleep 29.91 (14.06) 31.58 (33.77) .22
Latency to REM 92.69 (30.73) 84.03 (33.01) -.97
Percentage Wake 8.87 (5.11) 9.12 (7.14) .14
Percentage Stage 1 11.84 (6.41) 9.93 (6.98) -1.01
Percentage Stage 2 47.57 (7.51) 54.08 (12.01) 2.22*
Percentage SlowWave Sleep 16.99 (8.82) 9.41 (9.5) -2.94**
Percentage REM 14.7 (2.92) 17.44 (7.07) 1.68
* Indicates a significant difference between the three groups at p<.05
** Indicates a significant difference between the three groups at p<.01
Table 3: Group Differences Based on Baseline Characteristics (Sleep Parameters, Stress and Mood)
Baseline Variable Cluster
Normal Sleepers               
(n = 21)
Natural Remitters             
(n = 19)
F
Demographics
Age 34.14 (13.78) 29.74 (10.99) 1.58
Sex 13 Female (61.91%) 15 Female (78.95%) X
2
 = 2.08
Sleep Continuity (Diary)
Sleep Latency (minutes) 14.53 (9.73)ab 24.68 (14.78)a 6.59**
Number of Awakenings .89 (.78) 1.46 (1.14) 1.93
Wake After Sleep Onset (minutes) 11.12 (14.96)ab 19.64 (17.36)a 4.4*
Total Sleep Time (minutes) 433.35 (38.82)ab 386.29 (50.42)a 7.87***
% Sleep Efficiency 83.18 (8.42)ab 76.48 (5.99)a 5.92**
Measures of Stress
Life Event Scale Scores 106.63 (61.57)ab 176.26 (94.2)a 4.29*
Perceived Stress Scores 26.1 (4.25)ab 29.42 (4.48)a 3.34*
HADS: Anxiety 4.62 (3.06)ab 8.58 (4.3)a 13.94***
HADS: Depression 1.38 (2.04)ab 4.53 (3.36)a 11.59***
PSG Sleep Continuity
Sleep Latency (minutes) 8.31 (8.32) 12.79 (17.68) 0.64
Number of Awakennings 4.45 (2.14) 4.05 (2.84) 0.24
Wake After Sleep Onset (minutes) 30.45 (18.69) 34.32 (28.27) 0.12
Total Sleep Time (minutes) 402.02 (62.47) 394.18 (51.49) 0.49
% Sleep Efficiency 90.83 (5.09) 88.78 (8.11) 0.55
PSG Sleep Architecture
Latency to Stage 1 9.64 (11.6) 8.32 (7.81) 0.12
Latency to Stage 2 13.81 (10.21) 7.85 (1.8) 0.35
Latency to Slow Wave Sleep 29.91 (14.06) 27.82 (27.05) 0.43
Latency to REM 92.69 (30.73)a 97.08 (36.76)b 4.75**
Percentage Wake 8.87 (5.11) 8.9 (7.39) 0.04
Percentage Stage 1 11.84 (6.41) 8.88 (6.09) 1.05
Percentage Stage 2 47.57 (7.51) 54.61 (12.81) 2.47
Percentage Slow Wave Sleep 16.99 (8.82)a 11.55 (10.06) 5.68**
Percentage REM 14.7 (2.92) 16.02 (5.95) 2.84
* Indicates a significant difference between the three groups at p<.05
** Indicates a significant difference between the three groups at p<.01
*** Indicates a significant difference between the three groups at p<.001
Letters sharing the same superscript indicate significant post-hoc differences
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